Clinical characteristics and PD-L1 expression in primary lung squamous cell carcinoma: A case series

BACKGROUND: Squamous cell lung carcinoma(SCLC), accounts for 20% of lung cancer(LC). The binding of programmed cell death 1(PD-1) to its ligand PD-L1 is a key checkpoint regulator of immune response, and overexpression of the latter leads to immune surveillance escape. This might represent an import...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernández-Trujillo, Liliana, Garcia-Robledo, Juan E., Zúñiga-Restrepo, Valeria, Sua, Luz F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7287140/
https://www.ncbi.nlm.nih.gov/pubmed/32551224
http://dx.doi.org/10.1016/j.rmcr.2020.101114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7287140/
https://www.ncbi.nlm.nih.gov/pubmed/32551224
http://dx.doi.org/10.1016/j.rmcr.2020.101114

Ejemplares similares